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Epinephrine increased Cl402 production from glucose-U-Cl4 sixfold in the presence of palmitate and twofold in its absence, but did not increase the oxidation of circulating chylomicron tripalmitin-Cl4 or palmitate-1 -C l4 Titratable fatty acid (FFA) uptake was less than . the palmitate-Cl4 uptake with the result that there was an exaggerated decrease in perfusate FFA specific activity. Recovery of chylomicron tripalmitin-Cl4 and palmitate-1 -Cl4 in myocardial triglyceride doubled, possibly as a result of increased exchange between endogenous triglyceride fatty acid and perfusate FFA. Increased glycerol release indicated that endogenous lipid turnover and utilization were enhanced. Hydrolysis and utilization of circulating triglyceride did not correlate with that predicted from studies of myocardial lipoprotein lipase. These experiments suggest that eninephrine: I) specifically stimulates glucose utilization, 2) increases the utilization of endogenous lipid, and 3) indirectly influences myocardial FFA uptake in the intact animal by virtue of its ability to elevate circulating levels of FFA rather than by a direct effect on myocardial extraction. chylomicron utilization; glucose metabolism; lipid metabolism; myocardial metabolism; perfused rat heart T HE INCREASED METABOLIC DEMAND produced by epinephrine in the perfused rat heart is accompanied by a twofold increase in oxygen consumption (6) and glucose oxidation (25), indicating that the relative contribution of glucose to the fuel of respiration is unchanged and that lipid remains the main energy source. Glycerol is recorded as pmoles/g heart, dry wt, rel ease i n 60 min.
The number of hearts i n each group is indicated i n parentheses.
* P < .OI vs.
control.
t P < -05 vs.
control. disappears as triglyceride is recovered in the perfusate FFA fraction.
Myocardial TP-Cl4 uptake (the sum of Cl4 recovered in COZ, myocardial lipids, and intermediates) increased by 30 % from I 8. IO =t I .76 to 25. I 5 h I .73 pmoles/g heart, dry wt, most of which was recovered in myocardial triglyceride (P < .o I ), although recovery in phospholipid also increased significantly (P < .o I). The difference in the recovery of Cl4 between the two groups cannot account for the differences in TP-Cl4 uptake. Glycerol release. In the presence of glucose and palmitate-1 -C14, 2.50 =t o. I o pmoles glycerol/g heart, dry wt per hour were released by the perfused heart (Table 2) . Epinephrine produced a two-to threefold increase in glycerol release in the presence of these substrates.
Glucose metabolism. Epinephrine elevated glucose uptake and lactate production to rates that were equal to or greater than those observed in the absence of circulating lipid. The elevation of glucose uptake in the absence of palmitate suggested that epinephrine might have specifically stimulated glucose utilization.
In Fig. I , the effect of epinephrine on glucose-U-C4 oxidation in the presence and absence of palmitate is shown. Thirty minutes after the addition of epinephrine, Cl402 production had increased six-to sevenfold over control rates in the presence of palmitate but only twofold in its absence. Although epinephrine had a relatively greater effect on glucose-U-Cl4 oxidation in the presence of palmitate, Cl402 production was only 25 % of that observed when glucose alone was the substrate.
DISCUSSION
Chylomicron triglyceride and fatty acids were equally effective in decreasing glucose uptake by the perfused rat heart although not to levels observed in diabetes (I 3). The inhibitory effects of fatty acid on glucose uptake and glycolysis are thought to be mediated partially by elevation of citrate levels within the cell and inhibition of phosphofructokinase (9, I T), and partially from the inhibition of pyruvate decarboxylation (I 9). Elevated levels of cytoplasmic DPNH due to predominance of lipid utilization (16) may contribute to the moderate elevation in lactate production.
The effect of epinephrine on glucose uptake and lactate formation was similar to that observed by Williamson (25). There are several interesting features of its effect on the metabolism of circulating lipid and on glucose in the presence of free fatty acids. in myocardial lipid without increased uptake is difficult to explain. However, since epinephrine stimulates endogenous lipid turnover and elevation of tissue FFA in rat diaphragm and heart (8), it is possible that the exchange between fatty acids derived from endogenous triglyceride and those in the medium was enhanced. This phenomenon occurs normally to a limited extent in the perfused rat heart (4, 22). The exaggerated decrease in palmitate-rCl4 specific activity is compatible with such an exchange and would offer an explanation for the increased recovery of palmitate-1 -Cl4 in myocardial lipid without involving a net increase in FFA transport.
If such were the case, a decreased specific activity of tissue FFA and their CoA derivatives would be expected and Cl402 from labeled perfusate FFA would be decreased even though the actual CO2 production may have remained unchanged or increased. The diminished Cl402 produced by epinephrine and also observed with hearts of alloxandiabetic and starved rats in the preceding paper may be partially due to this phenomenon.
However, this does not reconcile the difference between these data and those of Gousios and Felts (I I) and Gold et al. ( I 0) . A 30 % increase in Cl402 production from palmitate-1 -Cl4 has been demonstrated with both epinephrine and norepinephrine in the perfused rabbit heart (I I). Since a recirculatory apparatus was not used, changes in fatty acid concentration were determined by A-V differences of lipid-bound radioactivity and changes in specific activity may not have been appreciated.
Comparison with the results obtained from the in situ perfusion of dog hearts (IO) is more difficult since the action of norepinephrine on peripheral FFA release also has to be considered. Despite a fall in palmitate-1 -Cl4 specific activity due to the peripheral lipolytic action of norepinephrine and in Cl402 production, the fraction of arterial palmitate-Cl4 appearing as Cl402 increased, leading to the conclusion that norepinephrine increased free fatty acid It is of interest to note that these observatcions were made in the absence of any increase in oxygen consumption.
As with the hearts of diabetic rats, the uptake of chylomicron triglyceride did not correlate with that which might be expected from the levels of LPL observed following chronic administration of epinephrine to rats in vivo (I). The discrepancy may be due to the relatively brief in vitro nature of the present experiments since administration of a single dose of epinephrine in vivo also did not alter LPL content (I). Yet LPL content can be influenced acutely as demonstrated by the twofold increase following 60 min of exercise in rats (I 5). Rat heart has been shown to contain more than one lipase (2) and, since glycerol release was increased acutely, it is possible that epinephrine's effect on myocardial lipolytic activity was mediated through activation of a specific lipase, similar to its mechanism of action on adipose tissue (24). A role for lipoprotein lipase in endogenous lipid turnover cannot be excluded, as it has been demonstrated that 70 % of myocardial LPL is microsomal bound (I ). Not only was there no increase in circulating triglyceride uptake, but hydrolysis was also unchanged.
This may be due to the relatively low concentration of chylomicron triglyceride (equivalent to 50 mg/~ oo ml available in the perfusate), the high lipolytic activity of rat heart (5), or the release of lytic enzyme into the perfusate (3). In this regard, it would be of interest to determine whether hydrolysis of perfusate chylomicron triglyceride would continue after removal of the hearts from the perfusion apparatus.
In conclusion, the data suggest that epinephrine specifically increases glucose oxidation and endogenous lipid turnover in the isolated perfused rat heart but does not stimulate oxidation of exogenous triglyceride or fatty acid. Since fatty acid utilization by liver (21), skeletal muscle (7), and heart (4) is related to concentration, it is likely that epinephrine increases myocardial FFA uptake by virtue of its ability to elevate circulating FFA, rather than by a direct effect on myocardial lipid extraction.
A similar conclusion has been reached by Gold and his co-workers (I 0). Am. J. Physiol. 194: 379-386, 1958. 8. GARLAND, P. B., AND P. J. RANDLE. Effect of alloxan diabetes and adrenaline on concentrations of free fatty acids in rat heart and diaphragm.
